40 results about "Commiphora mukul" patented technology

The invention discloses a color-changeable lipstick and a preparation method thereof. The color-changeable lipstick is prepared from the following components: mineral fat, isodecyl palmitate, candelilla wax, ozokerite, microcrystalline wax, butyrospermum parkii butter, tocopheryl acetate, isononyl isononanoate, hydrogenated polycyclopentadiene, caprylic / capric triglyceride, diisostearyl malate, hydrogenated polyisobutene, polyethylene, CI 45410, yellow No.5 lake, citric acid, silica, commiphora mukul resin extract, astaxanthin, purple coneflower extract and the balance of polyglyceryl-2 triisostearate. The color-changeable lipstick disclosed by the invention has the characteristics of firm and lasting color and luster, good concealing property and good lip-care effect. By adopting the color-changeable lipstick disclosed by the invention, people can experience a joyful feeling caused by lip gloss while enjoying lip treatment.

The invention discloses a breast enlarging and beautifying additive for cosmetics, belonging to the field of cosmetics. The additive consists of the following components in percentage by weight: 5.0-79.0% of kigelia pinnata fruit extract, 3.0-61.0% of black soybean estrogen, 1.0-28.0% of commiphora mukul resin, 1.0-45.0% of hops extract, 1.0-45.0% of leonurus sibiricus extract, 1.0-44.0% of sage essential oil, 1.0-34.0% of cananga odorata essential oil and 1.0-21.0% of basil essential oil. The additive disclosed by the invention is formed by mixing the natural extract and the plant essential oil, has natural smell, does not contain additives, realizes an obvious effect on enlarging and beautifying the breast, and is safe without toxic side effect; and the additive is added to cosmetics and is suitable for long-term use without causing irritation. In the invention, the components can be used as cosmetic additives and are suitable to be matched with cosmetics; and a series of breast enlarging and beautifying cosmetics prepared from the additive disclosed by the invention have good effect and low toxicity, conform to the requirements of the national law on cosmetics, and can meet theurgent needs of a great number of women not satisfied with the breast.

The subject invention pertains to supercritical carbon dioxide extracts of Commiphora mukul resin (guggul), which can be modified or not modified by some ethanol addition; methods for their production; and methods of use, such as inhibiting HMG-CoA reductase, inhibiting transformation of pre-adipocytes to adipocytes, inhibiting triglyceride storage, promoting insulin sensitivity in adipocytes, treatment of disorders (for example, hypercholesterolemia, hyperlipidemia, hyperglycemia, obesity, metabolic syndrome, cardiovascular disease, atherosclerotic heart disease, autoimmune disorder, insulin resistance, leptin resistance, arthritis, cell proliferation disorder, such as cancer and atherosclerosis; damaged skin, sores, cuts, rashes, bruises, dryness, burns, sunburn, radiation burn, and infection), and regulating or suppressing appetite.

A process for the isolation of a lipid fraction containing Z & E guggulsterones useful as cholesterol lowering drug, which comprises soaking / soxhlet extracting the powdered aerial part of the plant C. wightii with a non polar solvent, filtering / deanting the extract, soaking the material again in a polar solvent, filtering and concentrating the extracted material under reduced pressure as to obtain a thick viscous extract, and subjecting the thick viscous extract to gel filteration / silica gel chromatography to obtain Z & E ketosteroid containing lipid fraction exhibiting hypolipidemic activity.

The invention specifically discloses a composition capable of promoting differentiation of autologous preadipocytes and formation of lipid droplets and a preparation method thereof. A commiphora mukul resin extract and a recombinant human epidermal growth factor (rhEGF) are main components of the composition; and the content of the components are that the commiphora mukul resin extract is 1.0 to 3.0% and the recombinant human epidermal growth factor (rhEGF) accounts for 0.01 to 0.10%. According to the invention, the commiphora mukul resin extract and the recombinant human epidermal growth factor are organically combined together; on the one hand, differentiation of autologous preadipocytes is promoted by the recombinant human epidermal growth factor, on the other hand, activity of lipase in decomposition of fat is inhibited by the commiphora mukul resin extract, so formation and accumulation of lipid droplets are promoted, and thus, the volume of a breast can be effectively increased.

The invention discloses a skin care composition with a chest enlarging function and an application of the skin care composition to a cosmetic. The skin care composition with the chest enlarging function contains active components such as commiphora mukul resin extract, kigelia Africana fruit extract, pueraria lobata extract and yeast extract. The composition takes full advantages of the components, nourishes and moisturizes chest skins, promotes metabolism, exogenously supplements oestrogen-like hormone, safely promotes mammary tissue development, increases fat content and realizes compaction and bulging of chests.

Disclosed is a method for reducing the appearance of a wrinkle on skin comprising topically applying to said wrinkle a composition that includes an effective amount of ornithine, retinol, Commiphora mukul resin or an extract thereof, and hyaluronic acid, wherein topical application of the composition reduces the appearance of said wrinkle within 120 seconds after application of the composition, and wherein topical application of said composition stimulates adipogenesis in said skin.

Herbal compositions are useful for inhibition, amelioration or prevention of adipogenesis mediated diseases such as obesity, lipid storage disease and hyperlipemia. The herbal compositions comprise biologically effective amounts of extracts or fractions from Piper betle in combination with one or more of the extracts or fractions derived from Dolichos biflorus, Commiphora mukul, Boerhaavia diffusa, Tribulus terrestris and Zingiber officinale as active ingredients. The compositions optionally contain a bio-enhancing agent or a bio-protecting agent, along with biologically acceptable carriers or diluents. The herbal compositions may be used in a method for treating or preventing adipogenesis involved diseases in mammals.

Herbal compositions are useful for inhibition, amelioration or prevention of adipogenesis mediated diseases such as obesity, lipid storage disease and hyperlipemia. The herbal compositions comprise biologically effective amounts of extracts or fractions from Piper betle in combination with one or more of the extracts or fractions derived from Dolichos biflorus, Commiphora mukul, Boerhaavia diffusa, Tribulus terrestris and Zingiber officinale as active ingredients. The compositions optionally contain a bio-enhancing agent or a bio-protecting agent, along with biologically acceptable carriers or diluents. The herbal compositions may be used in a method for treating or preventing adipogenesis involved diseases in mammals.

The subject invention pertains to supercritical carbon dioxide extracts of Commiphora mukul resin (guggul), which can be modified or not modified by some ethanol addition; methods for their production; and methods of use, such as inhibiting HMG-CoA reductase, inhibiting transformation of pre-adipocytes to adipocytes, inhibiting triglyceride storage, promoting insulin sensitivity in adipocytes, treatment of disorders (for example, hypercholesterolemia, hyperlipidemia, hyperglycemia, obesity, metabolic syndrome, cardiovascular disease, atherosclerotic heart disease, autoimmune disorder, insulin resistance, leptin resistance, arthritis, cell proliferation disorder, such as cancer and atherosclerosis; damaged skin, sores, cuts, rashes, bruises, dryness, burns, sunburn, radiation burn, and infection), and regulating or suppressing appetite.

A novel herbal formulation for the prevention and management of various CHD risk factors including vascular inflammatory process responsible for cardiovascular events comprising a hydro-alcoholic extraction of commiphora mukul, Terminalia arjuna, Inula recemosa and Hippophae rhamonoides with or without known additives.

The invention discloses a traditional Chinese medicine for treating sepsis. The traditional Chinese medicine is prepared from the following medicinal materials in parts by weight: 10 parts of rattletop, 15 parts of root of common peony, 10 parts of the root bark of the peony tree, 30 parts of honeysuckle flower, 15 parts of fructus forsythiae, 10 parts of red halloysite, 6 parts of raw rhubarb, 10 parts of Scutellaria baicalensis, 5 parts of Coptis chinensis, 8 parts of Commiphora mukul, 5 parts of patrinia, 10 parts of Radix Ophiopogonis, 5 parts of short-tube lycoris, 6 parts of the root of bidentate achyranthes, 5 parts of Mirabilis himalaica and 3 parts of Pouzolzia elegans. The clinical experiment proves that proper medicinal materials and ratios thereof are selected, the obvious effect of effectively treating the sepsis is achieved, and the traditional Chinese medicine is safe and does not have any toxic or side effect.

Disclosed is a method for reducing the appearance of a wrinkle on skin comprising topically applying to said wrinkle a composition that includes an effective amount of ornithine, retinol, Commiphora mukul resin or an extract thereof, and hyaluronic acid, wherein topical application of the composition reduces the appearance of said wrinkle within 120 seconds after application of the composition, and wherein topical application of said composition stimulates adipogenesis in said skin.

The invention discloses a traditional Chinese medicine for treating intercostal neuralgia. The traditional Chinese medicine is prepared from the following medicinal materials in parts by weight: 10 parts of dried tangerine peel, 10 parts of prepared pinellia tuber, 12 parts of toddalia asiatica, 8 parts of raw liquorice, 8 parts of fried fructus aurantii, 8 parts of radix curcumae, 10 parts of toosendan fruit, 10 parts of rhizoma corydalis, 10 parts of sliced finger citron, 4 parts of commiphora mukul, 5 parts of resina populi, 8 parts of glycosmis pentaphylla, 10 parts of Himalaya mirabilis jalapa and 5 parts of mock orange root bark. Proved by clinical trials, through selecting appropriate medicinal materials and a proportioning ratio thereof, the traditional Chinese medicine achieves a remarkable effect on the treatment of intercostal neuralgia, is safe and is free from toxic or side effects.

The invention discloses a soil conditioner containing a microalga fermentation solution, and a preparation method and an application thereof. The soil conditioner comprises, by weight, 23-35 parts ofthe microalga fermentation solution, 15-21 parts of hydrogenated polydecene, 10-22 parts of Commiphora mukul resin extract, 13-24 parts of a dextran sodium chloride injection, 3-8 parts of flue ash and 4-10 parts of hair powder. The soil conditioner is mainly prepared from the microalga fermentation solution, hydrogenated polydecene, Commiphora mukul resin extract, the dextran sodium chloride injection, flue ash and hair powder, and can effectively condition soil, improve the drought resistance, the water and fertilizer utilization efficiency, the yield and the quality of soybeans and improvethe tobacco yield and quality.

The invention discloses a breast enlarging and beautifying additive for cosmetics, belonging to the field of cosmetics. The additive consists of the following components in percentage by weight: 5.0-79.0% of kigelia pinnata fruit extract, 3.0-61.0% of black soybean estrogen, 1.0-28.0% of commiphora mukul resin, 1.0-45.0% of hops extract, 1.0-45.0% of leonurus sibiricus extract, 1.0-44.0% of sage essential oil, 1.0-34.0% of cananga odorata essential oil and 1.0-21.0% of basil essential oil. The additive disclosed by the invention is formed by mixing the natural extract and the plant essential oil, has natural smell, does not contain additives, realizes an obvious effect on enlarging and beautifying the breast, and is safe without toxic side effect; and the additive is added to cosmetics and is suitable for long-term use without causing irritation. In the invention, the components can be used as cosmetic additives and are suitable to be matched with cosmetics; and a series of breast enlarging and beautifying cosmetics prepared from the additive disclosed by the invention have good effect and low toxicity, conform to the requirements of the national law on cosmetics, and can meet theurgent needs of a great number of women not satisfied with the breast.

The invention relates to the field of daily chemicals and discloses a plant compound breast augmentation and invigoration composition. The plant compound breast augmentation and invigoration composition comprises the following ingredients in percentage by mass: 1-5% of wild kudzuvine root extract, 1-5% of polygoni cuspidati radix extract, 0.2-4% of cimicifuga racemosa root, 0.2-4% of Chinese angelica root extract, 0.2-3% of pomegranate bark extract, 0.2-3% of red clover flower and inflorescence, 0.1-2% of hydrolyzed collagen, 0.2-5% of anemarrhena rhizome extract, 0.2-5% of glycyrrhiza glabraroot extract and 0.2-10% of commiphora mukul resin extract. The composition is safe and effective and can enhance breast dimensionality of a human body.

The invention discloses traditional Chinese medicine capsules for treating nocturia. The capsules are prepared from traditional Chinese medicinal materials in parts by weight as follows: 10 parts of Chinese yams, 7 parts of prepared rehmannia roots, 4 parts of oriental waterplantain rhizomes, 5 parts of tree peony bark, 1.5 parts of cassia bark, 6 parts of all-grass of bulley herminium, 9 parts of prepared common monkshood daughter roots, 6 parts of palmleaf raspberry fruits, 5 parts of semiaquilegia seeds, 4 parts of Borassus flabellifer, 3 parts of rhubarb, 6 parts of smallage seeds, 3 parts of Commiphora mukul, 4 parts of willow leaves, 6 parts of piptostegia roots and 9 parts of semen lepidii. Clinical experiments prove that through selection of the proper medicinal materials and ratio of the medicinal materials, the capsules have the significant effect of treating the nocturia and are safe and free of toxic and side effects.

The invention discloses a traditional Chinese medicine decoction for treating urinary system infection. The decoction is prepared from traditional Chinese medicinal materials in parts by weight as follows: 18 parts of nicandra, 12 parts of commiphora mukul, 8 parts of blaps rynchopetera fairmaire, 6 parts of lepidium sativum seeds, 15 parts of mantis egg-cases, 12 parts of christina loosestrife, 10 parts of Chinese thorowax roots, 10 parts of baical skullcap roots, 10 parts of scoliid honeycombs, 10 parts of dandelions, 12 parts of levant cotton, 5 parts of hornwort, 8 parts of raw liquorice roots, 8 parts of narrowleaf screwtree roots, 8 parts of oysters, 5 parts of figwort roots and 6 parts of milkweed. Clinical tests prove that through selection of the proper traditional Chinese medicinal materials and the ratio of the materials, the decoction can realize the significant effect of treating the urinary system infection and is safe and free of toxic and side effects.

The invention discloses medicinal wine for treating ischialgia. The medicinal wine is prepared from the following Chinese medicinal herbs by weight: 30 parts of root of slenderflower stephania, 25 parts of jalapa root, 20 parts of radix cyathulae, 18 parts of papaya, 15 parts of ephedra, 12 parts of tenacious condorvine stem, 10 parts of kadsura pepper stem, 12 parts of carthamus tinctorius, 15 parts of finless eel blood, 18 parts of commiphora mukul, 22 parts of smallage seeds and 12 parts of tuberous sword fern tuber. A preparation method for the medicinal wine comprises the following steps: (1) mixing the Chinese medicinal herbs, and grinding the mixture into coarse powder for standby application; (2) folding the coarse powder in a piece of gauze to obtain a traditional Chinese medicine package, putting the traditional Chinese medicine package into a container, adding 700 parts of 52-degree Baijiu for soaking, sealing the container, and then putting the sealed container in a cool and dry place for 30-90 days; (3) taking the soaked traditional Chinese medicine package out of the container, and carrying out filtration and sub-packaging. Clinical trials prove that due to selection of the suitable Chinese medicinal herbs and the certain weight ratio, the medicinal wine has a remarkable efficacy of treating ischialgia, and is safe and free of toxic and side effect.

The invention discloses a traditional Chinese medicine capsule for treating sudden dizziness. The traditional Chinese medicine capsule is prepared from the following traditional Chinese medicinal materials in parts by weight: 7 parts of cassia siamea leaves, 6 parts of common alstonia leaves, 6 parts of patrinia heterophylla bunge, 5 parts of codonopsis pilosula, 8 parts of rhizoma atractylodis macrocephalae, 5 parts of angelica sinensis, 6 parts of salviae miltiorrhizae, 8 parts of kudzu vine roots, 10 parts of radix bupleuri, 5 parts of beonninghausenia sessilicarpa, 5 parts of rhizoma cimicifugae, 8 parts of rhizoma atractylodis, 5 parts of purslane speedwell herb, 5 parts of agrimonia pilosa, 4 parts of pyrethrum carneum roots, 7 parts of crow liver, 4 parts of commiphora mukul, 5 parts of pittosporm roots, 4 parts of balaps japanensis yunnanensis, 15 parts of broadbeaked mustard and 6 parts of sugared tangerine exocarp. Clinical experiments prove that the reasonable combination of the Dai-native cassia siamea leaves and other traditional Chinese medicinal materials is beneficial to treatment of sudden dizziness, so that the relapse rate can be effectively reduced, and an excellent effect of integral adjustment and long-term effect can be achieved.

The invention discloses a Chinese herbal capsule for treatment of chronic bronchitis. The Chinese herbal capsule is prepared from the following Chinese herbal medicines by weight: 18 parts of loquat leaf, 15 parts of Salix araeostachya Schneid bark, root and leaf, 14 parts of Chinese yam, 10 parts of lily, 9 parts of Glehnia littoralis, 8 parts of bighead atractylodes rhizome, 7 parts of poria cocos, 6 parts of Salvia Miltiorrhiza, 7 parts of dried tangerine peel, 8 parts of prepared pinellia tuber, 9 parts of hairyvein agrimony, 10 parts of Flos Farfarae, 9 parts of commiphora mukul, 12 parts of sea hare ova, 7 parts of atractylodes lancea, 16 parts of Semen Lepidii sativa, 10 parts of Cassia siamea leaf, 9 parts of Folium Alstoniae Scholaris, 14 parts of hirsute gonostegia herb with root, 7 parts of Potamogeton perfoliatus Linn, 6 parts of folium artemisiae argyi, and 5 parts of Selaginella picta. Clinical experiments prove that through rational compatibility of Chinese herbal medicines, the Chinese herbal capsule provided by the invention is conducive to treatment of chronic bronchitis, has the characteristics of quick cure and difficult recurrence, and achieves the good efficacy of overall regulation and long-term effects.

The invention discloses a traditional Chinese medicine ointment for treating severe periarthritis of shoulder, which is prepared from the following traditional Chinese medicinal materials in parts by weight: 12 parts of mulberry twigs, 12 parts of prepared rehmannia root, 10 parts of achasma yunnanense, 8 parts of chuanxiong rhizome, 6 parts of ginger flower, 12 parts of stephania hernandifolia, 15 parts of salix araeostachya, 6 parts of hedyotis uncinella, 8 parts of burdock, 8 parts of stiff silkworm, 4 parts of bupleurum, 4 parts of oyster, 18 parts of astragalus root, 8 parts of commiphora mukul, 6 parts of halenia elliptica, 5 parts of disporum cantoniense, 4 parts of mesua ferrea flower, 3 parts of chinarue, 2 parts of gingko pollen, 5 parts of sapium baccatum and 4 parts of holly leaf. Clinical experiments prove that by selecting appropriate medicinal materials and proportions thereof, the traditional Chinese medicine ointment achieves an obvious effect on treating severe periarthritis of shoulder and is safe and free of toxic or side effect.

The invention discloses traditional Chinese medicine decoction for treating chronic orchitis. The traditional Chinese medicine decoction is prepared from the following traditional Chinese medicinal materials in weight proportion: 12 parts of physalis angulata, 8 parts of goodyera brachystegia, 7 parts of scutellaria baicalensis, 6 parts of radix bupleuri, 6 parts of oysters, 5 parts of heteropanax fragrans, 6 parts of commiphora mukul, 8 parts of cortex albiziae, 7 parts of herba plantaginis, 8 parts of cordate houttuynia, 9 parts of flos sophorae, 10 parts of melissa officinalis, 12 parts of halenia elliptica, 11 parts of ziziphus apetala, 9 parts of virginia pepperweed seeds, 5 parts of wild semen canavaliae, 6 parts of rhizoma polygonati,7 parts of glehnia littoralis, 5 parts of radix ophiopogonis, 6 parts of Chinese wolfberries, 7 parts of radix paeoniae alba and 5 parts of mongolian snakegourd root. Clinical experiment results prove that through selecting the proper traditional Chinese medicinal materials according to the ratio, the decoction achieves the remarkable efficacy for treating chronic orchitis, and is safe and free of toxic and side effect.

The invention discloses traditional Chinese medicinal decoction for treating acute testitis. The traditional Chinese medicinal decoction is prepared from the following traditional Chinese medicinal materials in parts by weight: 12 parts of Indian kalimeris herb, 8 parts of goodyera brachystegia, 7 parts of scutellaria baicalensis, 6 parts of Chinese thorowax roots, 6 parts of oysters, 5 parts of morinda angustifolia, 6 parts of commiphora mukul, 8 parts of cortex albiziae, 7 parts of plantain herb, 8 parts of houttuynia cordata, 9 parts of sophora japonica, 10 parts of Japanese ardisia, 12 parts of halenia elliptica, 11 parts of zizyphus apetala, 9 parts of lepidium apetalum seeds, 5 parts of wild string beans, 6 parts of polygonatum, 7 parts of adenophora, 5 parts of ophiopogon japonicus, 6 parts of fructus lycii, 7 parts of radix paeoniae alba and 5 parts of radix trichosanthis. A clinical experiment shows that the remarkable effect of treating acute testitis can be achieved by selecting proper medicinal materials and a proper proportion and the traditional Chinese medicinal decoction is safe and free of toxic or side effects.

The invention discloses medicinal liquor for treating sciatica. The medicinal liquor is characterized by being prepared from traditional Chinese medicinal materials in parts by weight as follows: 30 parts of bark of Treebineleaf Acanthopanax, 25 parts of milkweed, 20 parts of radix cyathulae, 18 parts of motherwort herbs, 15 parts of ephedra, 12 parts of fruits of Rhus coriaria L., 10 parts of herbs of Hancock Pearleverlasting, 12 parts of rabdosia rubesens, 15 parts of proliferous euphorbia roots, 18 parts of commiphora mukul, 22 parts of Agapetes burmanica and 12 parts of pileostegia. A preparation method comprises steps as follows: (1) the traditional Chinese medicinal materials are mixed and then crushed into coarse powder for use; (2) the coarse powder is tightly wrapped with gauze, a traditional Chinese medicine bag is formed and placed into a container, 700 parts of 52%v / v white spirit are added for soaking, and then the container is sealed and placed in a cool and dry place for 30-90 days; (3) the traditional Chinese medicine bag is taken out, and split charging is performed after filtration is performed. Clinical tests prove that through selection of the proper traditional Chinese medicinal materials and the ratio of the materials, the medicinal liquor can realize the significant effect of treating the sciatica and is safe and free of toxic and side effects.

The invention discloses traditional Chinese medicinal capsules for treating acute testitis. The traditional Chinese medicinal capsules are prepared from the following traditional Chinese medicinal materials in parts by weight: 12 parts of Indian kalimeris herb, 8 parts of goodyera brachystegia, 7 parts of scutellaria baicalensis, 6 parts of Chinese thorowax roots, 6 parts of oysters, 5 parts of morinda angustifolia, 6 parts of commiphora mukul, 8 parts of cortex albiziae, 7 parts of plantain herb, 8 parts of houttuynia cordata, 9 parts of prunella vulgaris, 10 parts of dandelions, 12 parts of halenia elliptica, 11 parts of zizyphus apetala, 9 parts of lepidium apetalum seeds, 5 parts of wild string beans, 6 parts of polygonatum, 7 parts of adenophora, 5 parts of ophiopogon japonicus, 6 parts of fructus lycii , 7 parts of radix paeoniae alba and 5 parts of pine pollen disruption powder. A clinical experiment shows that the remarkable effect of treating acute testitis can be achieved by selecting proper medicinal materials and a proper proportion and the traditional Chinese medicinal capsules are safe and free of toxic or side effects.

The invention discloses a traditional Chinese medicine ointment for treating scapulohumeral periarthritis. The traditional Chinese medicine ointment is prepared from the following traditional Chinese medicinal materials by weight proportion: 15 g of ramulus mori, 12 g of radix rehmanniae preparata, 10 g of achasma yunnanensis, 8 g of ligusticum wallichii, 12 g of pometia tomentosa bark, 15 g of piper flaviflorum, 8 g of radix bupleuri, 8 g of concha ostreae, 18 g of tragacanth, 8 g of burdock, 8 g of bombyx batryticatus, 10 g of rhizoma smilacis glabrae, 8 g of pyrethrum cinerariifolium roots, 8 g of commiphora mukul resin, 6 g of cicuta virosa seeds, 5 g of sapium baccatum roots, 6 g of nidus vespae, 6 g of aizoon stonecrop herb, 4 g of leaves of Chinese ilex and 6 g of pine pollen disruption powder. Clinical experiments prove that through the selection of appropriate medicinal materials and proportion, the traditional Chinese medicine ointment achieves the remarkable efficacy of treating scapulohumeral periarthritis, and is safe and free of toxic and side effects.